Literature DB >> 19759137

Chloroquine administration does not prevent Nipah virus infection and disease in ferrets.

Jackie Pallister1, Deborah Middleton, Gary Crameri, Manabu Yamada, Reuben Klein, Tim J Hancock, Adam Foord, Brian Shiell, Wojtek Michalski, Christopher C Broder, Lin-Fa Wang.   

Abstract

Hendra virus and Nipah virus, two zoonotic paramyxoviruses in the genus Henipavirus, have recently emerged and continue to cause sporadic disease outbreaks in humans and animals. Mortality rates of up to 75% have been reported in humans, but there are presently no clinically licensed therapeutics for treating henipavirus-induced disease. A recent report indicated that chloroquine, used in malaria therapy for over 70 years, prevented infection with Nipah virus in vitro. Chloroquine was assessed using a ferret model of lethal Nipah virus infection and found to be ineffective against Nipah virus infection in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759137      PMCID: PMC2772715          DOI: 10.1128/JVI.01847-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The natural history of Hendra and Nipah viruses.

Authors:  H Field; P Young; J M Yob; J Mills; L Hall; J Mackenzie
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

3.  Experimental Nipah virus infection in pteropid bats (Pteropus poliocephalus).

Authors:  D J Middleton; C J Morrissy; B M van der Heide; G M Russell; M A Braun; H A Westbury; K Halpin; P W Daniels
Journal:  J Comp Pathol       Date:  2007-05       Impact factor: 1.311

4.  Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus.

Authors:  P L Young; K Halpin; P W Selleck; H Field; J L Gravel; M A Kelly; J S Mackenzie
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

Review 5.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

6.  Experimental Nipah virus infection in pigs and cats.

Authors:  D J Middleton; H A Westbury; C J Morrissy; B M van der Heide; G M Russell; M A Braun; A D Hyatt
Journal:  J Comp Pathol       Date:  2002 Feb-Apr       Impact factor: 1.311

7.  A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

Authors:  Katharine N Bossart; Zhongyu Zhu; Deborah Middleton; Jessica Klippel; Gary Crameri; John Bingham; Jennifer A McEachern; Diane Green; Timothy J Hancock; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Lin-Fa Wang; Christopher C Broder
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

8.  Subcellular localization and calcium and pH requirements for proteolytic processing of the Hendra virus fusion protein.

Authors:  Cara Theresia Pager; Mark Allen Wurth; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Chloroquine is effective against influenza A virus in vitro but not in vivo.

Authors:  David J Vigerust; Jonathan A McCullers
Journal:  Influenza Other Respir Viruses       Date:  2007 Sep-Nov       Impact factor: 4.380

10.  A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L.

Authors:  Cara Theresia Pager; Willie Warren Craft; Jared Patch; Rebecca Ellis Dutch
Journal:  Virology       Date:  2006-02-07       Impact factor: 3.616

View more
  41 in total

Review 1.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

Review 2.  Emerging paramyxoviruses: molecular mechanisms and antiviral strategies.

Authors:  Hector C Aguilar; Benhur Lee
Journal:  Expert Rev Mol Med       Date:  2011-02-24       Impact factor: 5.600

3.  Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study.

Authors:  Jeremy Seto; Liang Qiao; Carolin A Guenzel; Sa Xiao; Megan L Shaw; Fernand Hayot; Stuart C Sealfon
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

Review 4.  A treatment for and vaccine against the deadly Hendra and Nipah viruses.

Authors:  Christopher C Broder; Kai Xu; Dimitar B Nikolov; Zhongyu Zhu; Dimiter S Dimitrov; Deborah Middleton; Jackie Pallister; Thomas W Geisbert; Katharine N Bossart; Lin-Fa Wang
Journal:  Antiviral Res       Date:  2013-07-06       Impact factor: 5.970

5.  A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge.

Authors:  Jackie Pallister; Deborah Middleton; Lin-Fa Wang; Reuben Klein; Jessica Haining; Rachel Robinson; Manabu Yamada; John White; Jean Payne; Yan-Ru Feng; Yee-Peng Chan; Christopher C Broder
Journal:  Vaccine       Date:  2011-07-01       Impact factor: 3.641

Review 6.  Henipavirus infection of the central nervous system.

Authors:  Brian E Dawes; Alexander N Freiberg
Journal:  Pathog Dis       Date:  2019-03-01       Impact factor: 3.166

Review 7.  Zoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns.

Authors:  Patricia A Thibault; Ruth E Watkinson; Andres Moreira-Soto; Jan F Drexler; Benhur Lee
Journal:  Adv Virus Res       Date:  2017-02-02       Impact factor: 9.937

8.  Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.

Authors:  Alexander N Freiberg; Melissa N Worthy; Benhur Lee; Michael R Holbrook
Journal:  J Gen Virol       Date:  2009-11-04       Impact factor: 3.891

9.  Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model.

Authors:  Stuart D Dowall; Andrew Bosworth; Robert Watson; Kevin Bewley; Irene Taylor; Emma Rayner; Laura Hunter; Geoff Pearson; Linda Easterbrook; James Pitman; Roger Hewson; Miles W Carroll
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

10.  Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro.

Authors:  Mohamad Aljofan; Michael L Sganga; Michael K Lo; Christina L Rootes; Matteo Porotto; Adam G Meyer; Simon Saubern; Anne Moscona; Bruce A Mungall
Journal:  Virol J       Date:  2009-11-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.